SupPoRtive Exercise Programmes for Accelerating REcovery after major ABdominal Cancer surgery trial (PREPARE‐ABC): Pilot phase of a multicentre randomised controlled trial. (9th September 2021)

• Record Type: Journal Article
• Other Names: Hernon James investigator.; Saxton John investigator.; Jones Megan investigator.; Howard Gregory investigator.; Swart Ann Marie investigator.; Clark Allan investigator.; Stirling Susan investigator.; Turner David investigator.; Murdoch Jamie investigator.; Nortje Jurgens investigator.; Bach Simon investigator.; Fearnhead Nicola investigator.; Din Farhat investigator.; Stephens Alan investigator.; Lund Jonathan investigator.; Tou Samson investigator.; Kelly Seamus investigator.; Ziprin Paul investigator.; Dennis Robert investigator.; Smart Neil investigator.; Roxburgh Campbell investigator.; Simpson Alastair investigator.; Mishra Ami investigator.; Knight Katrina investigator.; Dresser Kerry investigator.
• Is Part Of: Colorectal disease. Volume 23:Number 11(2021)
• Page Start: 3008
• Page End: 3022
• Publication Date: 2021-09-09
• Subjects: Colon (Anatomy) -- Diseases -- Periodicals; Rectum -- Diseases -- Periodicals; 616.34
• DOI: 10.1111/codi.15856
• Languages: English
• ISSNs: 1462-8910

Abstract

Abstract: Aim: PREPARE‐ABC is a pragmatic multicentre randomised controlled trial including an internal pilot designed to assess the clinical and cost‐effectiveness of pre‐ and postoperative exercise in relation to short‐ and longer‐term postoperative recovery outcomes in colorectal cancer patients undergoing surgical resection. Here, we report on internal pilot phase data for the first 200 patients randomised to the trial, which included prespecified stop‐go criteria used to inform the decision to progress to the fully powered trial by the funder. Methods: Eligible and consenting patients are randomly assigned (1:1:1) to hospital‐supervised exercise, home‐supported exercise or treatment as usual (TAU). Randomisation is concealed but clinical teams providing treatment and participants are unmasked. Primary outcomes are 30‐day morbidity (Clavien‐Dindo) and 12‐month health‐related quality of life (Medical Outcomes Study Health Questionnaire). Here, we present findings from the prespecified pilot phase which assessed feasibility of site set up, recruitment, adherence and acceptability of trial processes to patients and site staff. Results: Between 9 November 2016 and 18 May 2018, 18 sites were set up, with 200 patients randomised to either hospital‐supervised exercise (68), home‐supported exercise (69) or treatment as usual (TAU) (63). Across the groups, 19 patients did not proceed to surgery or withdrew and 52% experienced a complication. Over half of the participants (57%) in the hospital‐supervised group attended ≥6 preoperative sessions and 50% attended ≥5 monthly postoperative exercise "booster sessions". In the home‐supported group, 70% patients engaged with ≥2 telephone support sessions in the preoperative phase and 80% engaged in ≥5 monthly telephone support "booster sessions". Adverse events were reported by 22 patients and three patients reported a serious adverse event. The majority of complications were Clavien‐Dindo grades 1–2; however, 16 patients experienced one or more Clavien‐Dindo grade 3–4 complication(s). Conclusions: Results of the internal pilot phase confirm the feasibility of site set‐up and patient recruitment, representativeness of the sample population and adequate adherence to hospital‐supervised and home‐supported exercise. On the basis of these positive results, progression to the fully‐powered trial was authorised by the funder.